|
|
|
Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time.
Sign up now!
Already registered? Please sign in.
Alternatively, please use our pay-per-view service. |
|
|
 |
Industry Events |
 |
5th Annual Clinical Trial Supply West Coast
23-24 May 2012, Hyatt Regency San Francisco Airport, San Francisco
Arena International’s 5th Annual Clinical Trial Supply West Coast conference is the best platform to find solutions to minimize your clinical supply costs and tackle the biggest challenges of managing your clinical supply chain.
More info >> |
|
 |
News and Press Releases |
 |
Pharmaceutical Giants Set to Lose Dominance in Urological Disorders Market
NEW YORK (GBI Research), 12 April 2012 - Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a new report by pharmaceutical intelligence expert GBI Research has found.
The new report* found that the global urological disorders market will witness multiple patent expiries between 2009 and 2017, including several of the top-selling blockbuster drugs in the Urinary Incontinence (UI), Benign Prostatic Hyperplasia (BPH), Urinary Tract Infection (UTI) and Interstitial Cystitis (IC) markets.
More info >> |
|
|
